Trial Profile
Co-Contribution of Rotavirus Vaccine and PCV in Reduction of Pediatric Hospital Visits in Young Children
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2015
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Rotavirus vaccine (Primary)
- Indications Gastroenteritis; Pneumococcal infections; Pneumonia; Rotavirus infections
- Focus Therapeutic Use
- 30 Oct 2015 New trial record
- 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy.